SCHEMBL4636562

SCHEMBL4636562

O=C(O)Oc1sccc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.40
KMT2A Q03164 7/20 0.39
ALDH1A1 P00352 3/20 0.39
HTT P42858 1/20 0.39
GAA P10253 3/20 0.34
TDP1 Q9NUW8 2/20 0.34
AGTR1 P30556 1/20 0.34
PKM P14618 1/20 0.34
MEN1 O00255 5/20 0.33
POLB P06746 2/20 0.33
KDM4E B2RXH2 2/20 0.33
HSD17B10 Q99714 1/20 0.33
OPRM1 P35372 1/20 0.33
PTPRC P08575 1/20 0.33
PTPN1 P18031 1/20 0.33
GSK3B P49841 1/20 0.32
NR4A1 P22736 1/20 0.32
RECQL P46063 1/20 0.32
ESR2 Q92731 1/20 0.32
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27680682 0.86 KMT2A (0.41) MAPTKMT2AALDH1A1HTTGAA
SCHEMBL27830742 0.80 KMT2A (0.41) MAPTKMT2AALDH1A1HTTGAA
SCHEMBL11027684 0.78 BCL9 (0.40) MAPTKMT2AALDH1A1HTTGAA
SCHEMBL9351950 0.77 GSK3B (0.41) MAPTKMT2AGAATDP1PKM
SCHEMBL10587921 0.77 KMT2A (0.37) MAPTKMT2AALDH1A1GAATDP1
SCHEMBL3671086 0.77 KMT2A (0.33) MAPTKMT2AALDH1A1TDP1MEN1
SCHEMBL10369277 0.75 KDM4E (0.33) MAPTKMT2AALDH1A1GAATDP1
SCHEMBL4634541 0.75 KMT2A (0.36) MAPTKMT2AALDH1A1TDP1MEN1
SCHEMBL3418797 0.75 POLB (0.40) MAPTKMT2AALDH1A1GAATDP1
SCHEMBL17629372 0.75 MAPT (0.33) MAPTKMT2AALDH1A1HTTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1742925-B1 SUBSTITUTED 5, 6, 7, 8-TETRAHYDRO-PYRIDO[4, 3-D]PYRIMIDINE-2-YL COMPOUNDS AND 5, 6, 7, 8-TETRAHYDRO-QUINAZOLINE-2-YL COMPOUNDS GRUENENTHAL GMBH (DE) 2014-04-23 EP disclosed
EP-1937271-A1 MICROANGIOPATHY TREATMENT AND PREVENTION Bayer HealthCare AG (DE) 2008-07-02 EP disclosed
EP-1933841-A1 COMBINATION THERAPY COMPRISING SUBSTITUTED OXAZOLIDINONES FOR THE PREVENTION AND TREATMENT OF CEREBRAL CIRCULATORY DISORDERS Bayer HealthCare AG (DE) 2008-06-25 EP disclosed
WO-2007042146-A1 MICROANGIOPATHY TREATMENT AND PREVENTION BAYER HEALTHCARE AG (DE) 2007-04-19 WO disclosed
WO-2007039134-A1 COMBINATION THERAPY COMPRISING SUBSTITUTED OXAZOLIDINONES FOR THE PREVENTION AND TREATMENT OF CEREBRAL CIRCULATORY DISORDERS BAYER HEALTHCARE AG (DE) 2007-04-12 WO disclosed
EP-1742925-A1 SUBSTITUTED 5, 6, 7, 8-TETRAHYDRO-PYRIDO[4, 3-D]PYRIMIDINE-2-YL COMPOUNDS AND 5, 6, 7, 8-TETRAHYDRO-QUINAZOLINE-2-YL COMPOUNDS Grünenthal GmbH (DE) 2007-01-17 EP disclosed
WO-2005105759-A1 SUBSTITUTED 5, 6, 7, 8-TETRAHYDRO-PYRIDO[4, 3-D]PYRIMIDINE-2-YL COMPOUNDS AND 5, 6, 7, 8-TETRAHYDRO-QUINAZOLINE-2-YL COMPOUNDS Grünenthal GmbH (DE) 2005-11-10 WO disclosed
EP-0589301-A1 Carboxynilides derivatives, process for their preparation and fungicidal compositions containing them BASF Aktiengesellschaft (DE) 1994-03-30 EP disclosed
EP-0321857-B1 Process for preparing aromatic hydroxycarboxylic acids BASF AG (DE) 1994-03-30 EP disclosed
EP-0379003-A1 Thiophene-2-carboxylic-acid derivatives, process for their preparation and their use in combating undesired plant growth BASF Aktiengesellschaft (DE) 1990-07-25 EP disclosed
EP-0328766-A1 Process for the preparation of aromatic dicarboxylic acids BASF Aktiengesellschaft (DE) 1989-08-23 EP disclosed
EP-0321857-A2 Process for preparing aromatic hydroxycarboxylic acids BASF Aktiengesellschaft (DE) 1989-06-28 EP disclosed
EP-0216279-B1 PROCESS FOR THE PREPARATION OF HALOGEN-THIOPHENE-2-CARBOXYLIC ACIDS HOECHST AKTIENGESELLSCHAFT (DE) 1989-05-24 EP disclosed
EP-0216279-A1 Process for the preparation of halogen-thiophene-2-carboxylic acids HOECHST AKTIENGESELLSCHAFT (DE) 1987-04-01 EP disclosed